Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
02/2010
02/25/2010US20100048893 Substituted arylalkanoic acid derivatives and use thereof
02/25/2010US20100048890 Conjugated small molecules
02/25/2010US20100048612 [1,2,4]triazolo[4,3-a]pyridazine derivatives such as 6-(2-chlorophenyl)-7-(4-chlorophenyl)-3-[[2-methyl-6-(trifluoromethyl)pyridin-3-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridine, used for the treatment of obesity and hyperlipemia, or as antidiabetic, antilipemic, anticholesterol and hypotensive agents
02/25/2010US20100048611 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydro-imidazopyridine and tetrahydrotriazolopyridine derivatives and use thereof
02/25/2010US20100048606 10-Substituted Cytisine Derivatives and Methods of Use Thereof
02/25/2010US20100048604 Ligands for Aldoketoreductases
02/25/2010US20100048601 HYDROCHLORIDE SALTS OF 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one AND PREPARATION PROCESS THEREFOR
02/25/2010US20100048600 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics
02/25/2010US20100048593 Deazaflavin compounds and methods of use thereof
02/25/2010US20100048588 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/25/2010US20100048576 PYRIDOPYRAZINES AND DERIVATIVES THEREOF AS ALK AND c-MET INHIBITORS
02/25/2010US20100048565 Benzimidazole derivatives
02/25/2010US20100048564 Fused bicyclic heteroaryl derivative
02/25/2010US20100048563 Substituted indolepyridinium as anti-infective compounds
02/25/2010US20100048560 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
02/25/2010US20100048559 PYRIDO(3,2-d)PYRIDMIDINES USEFUL FOR TREATING VIRAL INFECTIONS
02/25/2010US20100048557 Triazolopyridine JAK Inhibitor Compounds and Methods
02/25/2010US20100048556 Quinoxaline derivatives
02/25/2010US20100048554 Spirocyclic Cyclohexane Compounds
02/25/2010US20100048553 Spirocyclic Cyclohexane Compounds
02/25/2010US20100048552 such as N-ethyl-3-(9-ethyl-8-oxo-8,9-dihydro-3H-3,4,9-triaza-cyclopenta[a]naphthalen-7-yl)-5-methoxy-benzamide, used to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity
02/25/2010US20100048551 Tricyclic Compounds Useful as Inhibitors of Kinases
02/25/2010US20100048540 Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors
02/25/2010US20100048528 Heterocyclic compounds as inhibitors of beta-lactamases
02/25/2010US20100044686 Material for an organic electroluminescence device and an organic electroluminescence device
02/25/2010US20100043879 Luminescent solar collector
02/25/2010US20100043878 Luminescent solar collector
02/25/2010DE102008038376A1 Verfahren zur Herstellung von 3,7-Diaza-bicyclo[3.3.1]nonan-Verbindungen Process for the preparation of 3,7-diaza-bicyclo [3.3.1] nonane compounds
02/25/2010DE102008038221A1 7-Azaindolderivate 7-azaindole derivatives
02/25/2010CA2771226A1 New bradykinin b1 antagonists
02/25/2010CA2734831A1 Triazolopyridine compounds as pim kinase inhibitors
02/25/2010CA2734787A1 Substituted 5-aminopyrazoles and use thereof
02/25/2010CA2734398A1 7-azaindole derivatives
02/25/2010CA2732969A1 Novel compounds and their uses in diagnosis
02/24/2010EP2157093A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
02/24/2010EP2155749A1 Pyrrolopyridine derivatives and their use as bace inhibitors
02/24/2010EP2155748A1 Urotensin ii receptor antagonists
02/24/2010EP2155747A1 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
02/24/2010EP2155746A2 Diazaquinolones that inhibit prolyl hydroxylase activity
02/24/2010EP2155745A1 6-(pyrrolopyridinyl)-pyrimidine-2-yl-amine derivatives
02/24/2010EP2155744A1 Heteroaryl amide analogues as p2x7 antagonists
02/24/2010EP2155743A1 Imidazoquinolines with immuno-modulating properties
02/24/2010EP2155742A1 5-aminopyrazol-3-yl-3h-imidazo [4,5-b]pyridine derivatives and their use for the treatment of cancer
02/24/2010EP2155741A2 Selective bromination of perylene diimides and derivatives thereof under mild conditions
02/24/2010EP2155716A2 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
02/24/2010EP2155695A1 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
02/24/2010EP2155676A2 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
02/24/2010EP2155675A1 Kinase inhibitors, compositions thereof, and methods of use therewith
02/24/2010EP2029596B1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same
02/24/2010EP1954697B1 Peri condensed tricyclic compounds useful as antibacterial agents
02/24/2010EP1701956B1 Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
02/24/2010EP1636225B1 Pyridino 1,2-a pyrimidin-4-one compounds as anticancer agents
02/24/2010EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use
02/24/2010CN101657452A Heterocyclic derivatives as M3 muscarinic receptors
02/24/2010CN101657451A Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
02/24/2010CN101657450A oxazolidinone antibiotic derivatives
02/24/2010CN101657449A diphenyl-dihydro-imidazopyridinones
02/24/2010CN101657448A A novel and economical process for preparing (S,S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer
02/24/2010CN101654454A Preparation method of mitrazapine and intermediate product thereof
02/24/2010CN100591682C Substituted diaza-spiro-[4.5|-decane derivatives and their use as neurokinin antagonists
02/24/2010CN100591681C Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
02/24/2010CN100591680C Dihydrotetrabenazines and pharmaceutical compositions containing same
02/23/2010USRE41150 Poly(adenosine 5'-diphospho-ribose) polymerase (PARP) inhibitors; compounds based on thieno(4,3,2-ef)(2)benzazepin-6-one
02/23/2010USRE41149 Optically active pyridonecarboxylic acid derivatives
02/23/2010US7667046 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
02/23/2010US7667039 Antiinflammatory agents; chronic obstructive pulmonary disease; antihistamines; transplant rejection; antitumor agents
02/23/2010US7666892 N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}-4-(4-fluorophenoxy)benzenesulfonamide and N-{[(4S)-2,5-dioxoimidazolidinyl]methyl}[1,1'-biphenyl]-4-sulfonamide; chemical intermediates for enzyme inhibitors; especially as inhibitors of MMP12
02/23/2010US7666879 enzyme inhibitor; 2-{2-Fluoro-4-[7-(2-methyl-pyridin-4-yl)-imidazo[1,2-a]pyridin-3-yl]-phenyl}-N-(3-trifluoromethyl-phenyl)-acetamide; angiogenesis inhibitor; antitumor agent; treating hyperglycemia, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, autoimmune diseases, inflammation, and eye disorders
02/23/2010US7666878 Pyrrolopyridine derivatives and their use as Crth2 antagonists
02/23/2010US7666875 Hydantoin compounds
02/23/2010US7666869 Nitrogen-containing 5-membered ring compound
02/23/2010CA2462289C Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
02/18/2010WO2010019899A1 cMET INHIBITORS
02/18/2010WO2010019659A1 Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use
02/18/2010WO2010019098A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
02/18/2010WO2010019097A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient
02/18/2010WO2010018352A1 Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is implicated
02/18/2010WO2009155121A3 Inhibitors of pi3 kinase
02/18/2010WO2009150381A3 Azacarboline derivatives, preparation thereof, and therapeutic use thereof as kinase inhibitors
02/18/2010US20100041885 Crystalline forms of sitagliptin phosphate
02/18/2010US20100041694 Agricultural composition for controlling or preventing plant diseases caused by plant pathogenic microbes
02/18/2010US20100041693 Indolylmaleimide derivatives
02/18/2010US20100041692 Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use
02/18/2010US20100041683 Novel chain-breaking antioxidants
02/18/2010US20100041680 Piperidine derivatives
02/18/2010US20100041676 Kinase inhibitors
02/18/2010US20100041675 treatment of retinopathy comprising administering drugs such as tert-butyl 3-[5-ethyl-6-[4-(5,6,7,8-tetrahydro-(1,8)naphthyridin-2-yl)-piperidin-1-yl]-pyrimidin-4-ylamino]-2-(4-methoxy benzoyl)-propionate
02/18/2010US20100041670 monoacyl glycerol lipase and fatty acid amide hydrolase inhibitors such as [5-(2-chlorophenyl)[1,2,3]triazolo[4,5-b]pyridin-3-yl][4-(3-trifluoromethylphenyl) piperazin-1-yl]methanone, used as analgesics or for the treatment of vomiting and nausea
02/18/2010US20100041651 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
02/18/2010US20100041636 Novel kinase inhibitors
02/18/2010US20100041634 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
02/18/2010US20100041545 Catalysts and methods for catalytic oxidation
02/18/2010US20100040551 Animal Model of Central Neuropathic Pain and Methods of Making and Using the Same
02/18/2010US20100040548 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
02/18/2010US20100039705 Organic Compound, Anisotropic Optical Film and Method of Production Thereof
02/18/2010DE102008037790A1 Bicyclische Triazolderivate Bicyclic triazole derivatives
02/18/2010CA2733523A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a .beta.2-adrenoceptor agonist
02/18/2010CA2733447A1 Pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient
02/18/2010CA2733445A1 Pyrrolo[4,3,2-de]quinolin-8-amine compounds and methods of their preparation and use
02/18/2010CA2733247A1 Heterocyclic amide derivatives as ep4 receptor antagonists